申请人:Gobbi Luca
公开号:US20090029977A1
公开(公告)日:2009-01-29
The present invention relates to compounds of the formula (I)
wherein R
1
, R
2
, X and n are as defined in the specification as dual modulators of the serotonin 5-HT
2a
and dopamine D
3
receptors, their manufacture, pharmaceutical compositions containing them and their use for the treatment of psychotic disorders, as well as other diseases such as depression and anxiety, drug dependence, dementias and memory impairment.
本发明涉及公式(I)中R1、R2、X和n的化合物,其在说明书中被定义为5-HT2a和D3受体的双调节剂,它们的制备、含有它们的药物组合物以及它们用于治疗精神病性障碍以及其他疾病,如抑郁症、焦虑症、药物依赖、痴呆症和记忆障碍。